Volume 26, Issue 1 (Monthly_March 2015)                   Studies in Medical Sciences 2015, 26(1): 74-80 | Back to browse issues page

XML Persian Abstract Print


Psychology Department, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran , s.sheikhi@umsu.ac.ir
Abstract:   (7084 Views)

 

Background& Aims: Addictions affect an individual mentally, physically and socially. There are personal, interpersonal and social and environmental causes that interact in its development. The present study aimed to examine the effectiveness of cognitive behavior therapy and pharmacological intervention on increasing efficacy and improving the quality of life in men with substance use.      

Materials & Methods: This descriptive-analytical study was conducted on 40 men with substance selected by available sampling method and were divided into an experimental (n=20) and a control group (n=20). Pre-test and post-test was carried out and the data were collected using self-efficacy and World Health Organization Quality of Life Questionnaire. . Pharmacological interventions in both groups were under medical supervision, however, the experimental group received eight sessions of cognitive-behavioral therapy. The mean score of the two groups were compared by covariance analysis (ANCOVA).

Results: The results of study showed significant differences between the mean scores of the pre-test and post-test of the experimental and control groups. Cognitive therapy had enhancing in self-efficacy and quality of life mean score in the experimental group. (p<0/001).

Conclusion: The present findings indicate that pharmacological intervention with cognitive behavioral therapy can be useful in increasing self-efficacy and improving life quality in people with substance use.                          

 

SOURCE: URMIA MED J 2015: 26(1): 80 ISSN: 1027-3727

Full-Text [PDF 218 kb]   (1878 Downloads)    
Type of Study: Research | Subject: آناتومی

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.